StreetInsider.com News Articles

Form 8-K/A IRADIMED CORP For: Jul 31

Tue, 18 Aug 2026 14:04:00 -0400

si-local-file:///var/storage/secattach/20260818/26943415.html

Form 8-K/A IRADIMED CORP For: Jul 31

Tue, 18 Aug 2026 14:04:00 -0400

si-local-file:///var/storage/secattach/20260818/26943415.html

Iradimed Corp. (IRMD) Tops Q2 EPS by 1c ; Offers Guidance

Mon, 03 Aug 2026 05:31:57 -0400

Iradimed Corp. (NASDAQ: IRMD) reported Q2 EPS of $0.46, $0.01 better than the analyst estimate of $0.45. Revenue for the quarter came in at $20.5 million versus the consensus estimate of $20.56 million.

Outlook:-

Q3 2026 revenue between $23.0 million to $24.5 million vs consensus $91.2 million.
Q3 2026 EPS between $0.54 to $0.59 vs consensus $2.09.
FY 2026 revenue between $91.0 million to $96.0 million vs consensus $25.2 million.
FY 2026 EPS between $2.09 to $2.24 vs consensus $0.61.

For earnings history and earnings-related data on Iradimed Corp. (IRMD) click here.

Form 10-Q IRADIMED CORP For: Jun 30

Fri, 31 Jul 2026 16:10:00 -0400

si-local-file:///var/storage/secattach/20260731/26850821.html

Form 10-Q IRADIMED CORP For: Jun 30

Fri, 31 Jul 2026 16:10:00 -0400

si-local-file:///var/storage/secattach/20260731/26850821.html

Form 8-K IRADIMED CORP For: Jul 31

Fri, 31 Jul 2026 08:16:00 -0400

si-local-file:///var/storage/secattach/20260731/26847124.html

Form 8-K IRADIMED CORP For: Jul 31

Fri, 31 Jul 2026 08:16:00 -0400

si-local-file:///var/storage/secattach/20260731/26847124.html

IRADIMED CORPORATION Reports Second Quarter 2026 Financial Results

Fri, 31 Jul 2026 08:15:00 -0400

Announces Regular Quarterly Cash Dividend of $0.20 Per Share

Reaffirms Full-Year 2026 Revenue and Earnings Guidance

Reports revenue of $20.5 million for the second quarter of 2026, which increased by $0.1 million, or 0.5% compared to the same period in 2025.
Reports GAAP diluted EPS of $0.41 and non-GAAP diluted EPS of $0.46 for the second quarter of 2026.
Declares a regular quarterly cash dividend of $0.20 per share of common stock for the second quarter of 2026, payable on August 28, 2026.

ORLANDO, Fla., July 31, 2026 (GLOBE

IRADIMED CORPORATION Reports Second Quarter 2026 Financial Results

Fri, 31 Jul 2026 08:15:00 -0400

Announces Regular Quarterly Cash Dividend of $0.20 Per Share

Reaffirms Full-Year 2026 Revenue and Earnings Guidance

Reports revenue of $20.5 million for the second quarter of 2026, which increased by $0.1 million, or 0.5% compared to the same period in 2025.
Reports GAAP diluted EPS of $0.41 and non-GAAP diluted EPS of $0.46 for the second quarter of 2026.
Declares a regular quarterly cash dividend of $0.20 per share of common stock for the second quarter of 2026, payable on August 28, 2026.

ORLANDO, Fla., July 31, 2026 (GLOBE

Form SCHEDULE 13G IRADIMED CORP Filed by: BlackRock, Inc.

Tue, 28 Jul 2026 16:46:00 -0400

si-local-file:///var/storage/secattach/20260728/26827946.html

Form SCHEDULE 13G IRADIMED CORP Filed by: BlackRock, Inc.

Tue, 28 Jul 2026 16:46:00 -0400

si-local-file:///var/storage/secattach/20260728/26827946.html

IRADIMED CORPORATION to Hold Second Quarter 2026 Financial Results Conference Call on July 31, 2026

Fri, 24 Jul 2026 16:15:00 -0400

ORLANDO, Fla., July 24, 2026 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2026 second quarter financial results before the market opens on Friday, July 31, 2026. Iradimed management will host a conference call the same day beginning at 11:00 a.m. Eastern Time to discuss those results and to answer questions.

Individuals interested in participating in the conference call may do so by registering here, https://register-conf.media-server.com/register/BIc3b3caa4c4d94098970951ede5eb5d2e Once registered, a dial-in number, unique pin, and instructions will be provided to participants.

The conference call will

IRADIMED CORPORATION to Hold Second Quarter 2026 Financial Results Conference Call on July 31, 2026

Fri, 24 Jul 2026 16:15:00 -0400

The conference call will

Form 8-K IRADIMED CORP For: Jun 24

Wed, 24 Jun 2026 10:23:00 -0400

si-local-file:///var/storage/secattach/20260624/26683682.html

Form 8-K IRADIMED CORP For: Jun 24

Wed, 24 Jun 2026 10:23:00 -0400

si-local-file:///var/storage/secattach/20260624/26683682.html

Form 4 IRADIMED CORP For: Jun 20 Filed by: GLENN JOHN

Tue, 23 Jun 2026 09:29:00 -0400

si-local-file:///var/storage/secattach/20260623/26677182.html

Form 4 IRADIMED CORP For: Jun 20 Filed by: GLENN JOHN

Tue, 23 Jun 2026 09:29:00 -0400

si-local-file:///var/storage/secattach/20260623/26677182.html

Form 4 IRADIMED CORP For: Jun 04 Filed by: Scharen-Guivel Hilda Frederique

Thu, 04 Jun 2026 16:22:00 -0400

si-local-file:///var/storage/secattach/20260604/26606034.html

Form 4 IRADIMED CORP For: Jun 04 Filed by: Scharen-Guivel Hilda Frederique

Thu, 04 Jun 2026 16:22:00 -0400

si-local-file:///var/storage/secattach/20260604/26606034.html

Form 144 IRADIMED CORP Filed by: Scharen-Guivel Hilda Frederique

Thu, 04 Jun 2026 13:01:00 -0400

si-local-file:///var/storage/secattach/20260604/26604613.html

Form 144 IRADIMED CORP Filed by: Scharen-Guivel Hilda Frederique

Thu, 04 Jun 2026 13:01:00 -0400

si-local-file:///var/storage/secattach/20260604/26604613.html

Form 4 IRADIMED CORP For: Jun 01 Filed by: Susi Roger E.

Tue, 02 Jun 2026 14:26:00 -0400

si-local-file:///var/storage/secattach/20260602/26590738.html

Form 4 IRADIMED CORP For: Jun 01 Filed by: Susi Roger E.

Tue, 02 Jun 2026 14:26:00 -0400

si-local-file:///var/storage/secattach/20260602/26590738.html

Form 4 IRADIMED CORP For: May 26 Filed by: Susi Roger E.

Thu, 28 May 2026 15:08:00 -0400

si-local-file:///var/storage/secattach/20260528/26565860.html

Form 4 IRADIMED CORP For: May 26 Filed by: Susi Roger E.

Thu, 28 May 2026 15:08:00 -0400

si-local-file:///var/storage/secattach/20260528/26565860.html